Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Bharat Serums, Mankind Pharma
Mankind Pharma-Bharat Serums & Vaccines merger: Important update on Rs 13,630 crore plan - Details
Mankind, through its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and pharmaceutical product packaging.
CCI clears Rs 13,630-cr Mankind Pharma-Bharat Serums Vaccines deal
The Competition Commission of India (CCI) on Tuesday approved the proposed acquisition of Bharat Serums and Vaccines by Mankind Pharma for Rs 13,630 crore
CCI approves acquisition of Bharat Serums and Vaccines by Mankind Pharma
Competition Commission of India has approved the acquisition of Bharat Serums and Vaccines Limited by Mankind Pharma Ltd.
CCI approves Mankind Pharma's purchase of Bharat Serums for $1.6 bn
Mankind Pharma, which has brands including Manforce condoms and Prega News pregnancy tests, signed an agreement to acquire Bharat Serums
Mankind Pharma shares extend gain on CCI nod for BSV acquisition
The CCI has cleared Mankind Pharma's proposed acquisition of 100% stake in Bharat Serums and Vaccines for ₹13,630 crore.
Mankind Pharma gets CCI nod for BSV acquisition
Mankind Pharma Ltd. receives regulatory approvals for 100% acquisition of Bharat Serums and Vaccines Ltd. worth ₹13,630 crore.
CCI greenlights Mankind Pharma's Rs 13,630 crore takeover of Bharat Serums
The Competition Commission of India (CCI) has approved Mankind Pharma’s acquisition of Bharat Serums and Vaccines for ₹13,630 crore.
CCI Approves Mankind Pharma's Acquisition Of Bharat Serums And Vaccines For Rs 13,630 Crore
BSV is also recognized as a leader in women's healthcare, assisted reproductive treatments, and critical care.
CCI clears Rs 13,630-crore Mankind Pharma-Bharat Serums Vaccines deal
In July this year, Mankind Pharma announced that it will fully acquire Bharat Serums and Vaccines from private equity firm Advent International for around Rs 13,630 crore.
Mankind Pharma-BSV Acquisition: Rs 10,000 crore update from India’s 4th largest drug maker
In a regulatory filing to stock exchanges today, Mankind Pharma Ltd, the fourth-largest pharmaceutical company in India by market share, said that its board has approved raising up to Rs 5,000 crore through non-convertible debentures in 3-4 distinct series with maturities of upto 48 months.
Mankind Pharma's ₹13,630 crore acquisition of Bharat Serums and Vaccines approved by CCI
The Competition Commission of India has approved Mankind Pharma's ₹13,630 crore acquisition of Bharat Serums and Vaccines.
New York Magazine
1d
The 13 Very Best Vitamin-C Serums
Of all the
vitamin-C
options, our experts generally recommend looking for
serums
that contain ascorbic acid, also known as L-ascorbic acid, which is the most active and purest form of
vitamin C
.
moneycontrol.com
1d
Stock Radar: Eicher Motors, Hero MotoCorp, Mankind Pharma, Ashoka Buildcon, KRN Heat, ITC in focus on Thursday
In July 2024, the Share Purchase Agreement was executed between the company,
Bharat
Serums
and Vaccines, the sellers ...
2d
CCI approves Mankind Pharma’s acquisition of Bharat Serums and Vaccines
Deal involves Mankind buying 100 per cent equity in Bharat Serums from PE firm Advent International at an enterprise value of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
US adds 254,000 jobs
Accused of sexual assault
Registration deadlines
To be closed indefinitely
Jan. 6 charges dismissal bid
Nevada politician guilty
To stay at rescue center
Wreck of WWII ship found
Antarctica turning green
Plastic-eating bacteria
Murder case to be reviewed
Water fluoridation research
CDC flu vaccine report
3 pitching coaches fired
Free tax filing expansion
CA dairy workers infected
Settles overcharging lawsuit
India, US sign minerals pact
Processing times drop
Union skips endorsement
To weigh Mexico’s $10B suit
Senators urge DOJ action
Tropical Storm Leslie forms
Debt plan blocked again
First mpox test approved
Read seeks to delay lawsuit
Feedback